Summaries of Review for Applications to RFA 07-04

The following is a listing of all applications reviewed under RFA 07-04 for CIRM Disease Team Planning Awards. Applications include the score (between 0 and 100, with 100 being the best) and a funding recommendation (indicated by the color key below) made by the Grants Working Group (GWG) during the review meeting on April 9-10, 2008. A link to the Public Abstract (provided by applicant), Statement of Benefit to California (provided by applicant), and Public Review Report are available for each application by clicking on the respective application number.
 
= Recommended for funding
 

= Recommended to be available for
funding only if the ICOC makes a
programmatic determination to fund this application
 
= Not Recommended for funding


Application Number ICOC Decision Title Scientific Score
DT1-00652-1 Approved A CIRM Disease Team for the Treatment and Cure of Diabetes 94
DT1-00672-1 Approved Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes 92
DT1-00710-1 Approved {REDACTED} Cardiovascular Regenerative Team 92
DT1-00674-1 Approved Stem Cell Therapy for Muscular Dystrophy 90
DT1-00698-1 Approved {REDACTED} Heart Disease Regenerative Medicine Team Planning Award 90
DT1-00671-1 Approved Pluripotent Stem Cell–Based Therapy for Heart Disease 89
DT1-00657-1 Approved Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) 86
DT1-00683-1 Approved Stem Cell Therapy for AIDS- Disease Team Planning 85
DT1-00653-1 Approved Clinical Regenerative Wound Healing With Stem Cells 80
DT1-00688-1 Approved Develop a cell replacement therapy for Parkinson's disease using human embryonic stem cells 80
DT1-00700-1 Approved Huntington's Disease Team 80
DT1-00701-1 Approved STEM CELL GENE THERAPY FOR SICKLE CELL DISEASE 80
DT1-00704-1 Approved "Stem Cell Therapies for Heart Failure" 80
DT1-00697-1 Approved CIRM Disease Team Planning Award 79
DT1-00709-1 Approved CIRM Planning Grant in Leukemia 79
DT1-00708-1 Approved Genetically-modified neural stem cells for treatment of high-grade glioma 78
DT1-00659-1 Approved Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration 77
DT1-00669-1 Approved Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke 77
DT1-00690-1 Approved Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa 77
DT1-00696-1 Approved Stem Cell-Mediated Oncocidal Therapy of Primary & Metastatic Brain Tumors 76
DT1-00656-1 Approved A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage 75
DT1-00658-1 -- Allogeneic Mesenchymal Stem Cells for the Treatment of Acute Lung Injury 74
DT1-00675-1 Approved Human Stem Cell Approaches to Alzheimers Disease Therapies 73
DT1-00693-1 -- Melanoma Stem Cell 72
DT1-00702-1 -- Stem Cells for Vascular Tissue Regeneration 71
DT1-00650-1 -- Human Embryonic Stem Cells for Heart Failure 70
DT1-00668-1 -- Regenerative Strategies for Cardiac and Vascular Injury 70
DT1-00715-1 -- Stem Cell Mediated Therapy of Genetic Degenerative Childhood Disorders-Particularly Neurodegenerative Lysosomal Storage Diseases 69
DT1-00712-1 -- Stem Cell Therapies for Brain Tumors 68
DT1-00670-1 -- Stem Cell Therapy for the Lysosomal Storage Diseases, the Major Cause of Neurodegeneration in Children 66
DT1-00651-1 -- Planning optimal strategies for applications of stem and progenitor cell therapies in spinal cord injury --
DT1-00660-1 -- Early Breast Cancer Predictive Diagnostics: The Cancer Initiating Cell and Personalized Prevention in Breast Cancer --
DT1-00663-1 -- STEM CELL-BASED TREATMENT OF OROFACIAL TUMORS --
DT1-00664-1 -- Stem-Cell-Based Regenerative Therapies for Arthritis --
DT1-00665-1 -- Stem cell-based strategies for treatment of Alzheimer's and other neurodegenerative disease --
DT1-00666-1 -- Development of Cancer Stem Cell Niche Therapeutics --
DT1-00667-1 -- Cancer Stem Cell Therapeutic Targets Derived from Human Embryonic Stem Cells --
DT1-00673-1 -- Ex Vivo Small Molecule Induced Hematopoietic Stem Cell Expansion For Transplantation --
DT1-00676-1 -- Treatment of Type II Diabetes Mellitus: Mitochondrial Resuscitation + Beta Cell Supplementation --
DT1-00677-1 -- Mesenchymal stem cells for therapy of pulmonary fibrosis --
DT1-00678-1 -- Remyelination for the Treatment of Spinal Cord Injury --
DT1-00679-1 -- {REDACTED} California Team Planning for Rapid Translation of Mesenchymal Stem Cell (MSC)-based Research to Advance Islet Transplantation for Treatment of Type 1 Diabetes --
DT1-00680-1 -- To develop Stem cell derived corneal tissue as a substitute for donor-sourced cornea normally used for transplantation of partial thickness grafts --
DT1-00681-1 -- Development of novel therapeutics for stem-like cancer cells --
DT1-00682-1 -- Liver Disease Team for development of novel tools and antiviral therapies from human embryonic and pluripotent stem cells --
DT1-00684-1 -- Stem cell therapeutic capable of targeting pediatric brain tumors --
DT1-00685-1 -- Planning for a Type I and Type II Diabetes Disease Team --
DT1-00687-1 -- Musculoskeletal Tissue Regeneration --
DT1-00689-1 -- Treatment of Cardiac Arrhythmias by Stem Cell Therapies. --
DT1-00691-1 -- Development of Novel Therapeutic Strategies for Pulmonary Vascular Disease Using Stem Cells Derived From Patients' Diseased Arterial Tissues --
DT1-00692-1 -- Transendocardial Autologous Serum Autologous Mesenchymal Stem Cell delivery using Transendocardial Delivery For Heart Failure Trial --
DT1-00694-1 -- Development of A Cell-based Therapy for Cerebral Palsy --
DT1-00695-1 -- A translational research project for defining a stem cell formulation for treating ischemic stroke based on comparison of adult neural stem cells and neural stem cells derived from embryonic stem cells. --
DT1-00699-1 -- Feasibility and benefit-risk ratio of high cell dose allogeneic umbilical cord blood stem cell transplantation as a curative stem cell therapy for severe forms of autoimmune diseases --
DT1-00703-1 -- Stroke (Cerebral Ischemia) Disease Team of {REDACTED} --
DT1-00705-1 -- {REDACTED} Liver Cell Therapies Team --
DT1-00707-1 -- Neonatal Brain Ischemia: Neuroimaging as a Basis for Rational Stem Cell Therapy --
DT1-00711-1 -- Amniotic Fluid Stem Cell Therapy for Acute Lung Injury --
DT1-00714-1 -- Optimization of Stem Cell Transplantation to Treat Acute Myocardial Infarction --